awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36553517-4780C2B3-3ECC-477A-AD67-AACC416D9DDE
Q36553517-4780C2B3-3ECC-477A-AD67-AACC416D9DDE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36553517-4780C2B3-3ECC-477A-AD67-AACC416D9DDE
Metabolic complications with the use of mTOR inhibitors for cancer therapy
P2860
Q36553517-4780C2B3-3ECC-477A-AD67-AACC416D9DDE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36553517-4780C2B3-3ECC-477A-AD67-AACC416D9DDE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2bb72669e50ff5462587feefc723bd36f46b1e5c
P2860
A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: a trial of the Eastern Cooperative Oncology Group (